267 related articles for article (PubMed ID: 30523223)
21. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients.
Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
Dis Esophagus; 2012 Apr; 25(3):242-9. PubMed ID: 21895853
[TBL] [Abstract][Full Text] [Related]
22. Serum miR-1297: a promising diagnostic biomarker in esophageal squamous cell carcinoma.
Wang C; Li Q; Liu F; Chen X; Nesa EU; Guan S; Liu B; Han L; Tan B; Wang D; Chen P; Liu X; Zhang H; Sun Y; Cheng Y
Biomarkers; 2016 Sep; 21(6):517-22. PubMed ID: 27152453
[TBL] [Abstract][Full Text] [Related]
23. [Value of the concentration and integrity of serum cell-free DNA for the clinical diagnosis of esophageal carcinoma].
Qiu YW; Shen XJ; Jin CJ; Cao XJ; Ju SQ
Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):905-910. PubMed ID: 30605980
[No Abstract] [Full Text] [Related]
24. Predictive significance of CYFRA21-1, squamous cell carcinoma antigen and carcinoembryonic antigen for lymph node metastasis in patients with esophageal squamous cancer.
Mei X; Zhu X; Zuo L; Wu H; Guo M; Liu C
Int J Biol Markers; 2019 Jun; 34(2):200-204. PubMed ID: 31088185
[TBL] [Abstract][Full Text] [Related]
25. Elevated serum eotaxin and IP-10 levels as potential biomarkers for the detection of esophageal squamous cell carcinoma.
Chang C; Wang MJ; Bi XF; Fan ZY; Feng D; Cai HQ; Zhang Y; Xu X; Cai Y; Qi J; Wei WQ; Hao JJ; Wang MR
J Clin Lab Anal; 2021 Sep; 35(9):e23904. PubMed ID: 34288108
[TBL] [Abstract][Full Text] [Related]
26. Serum miRNA expression in patients with esophageal squamous cell carcinoma.
Hui B; Chen X; Hui L; Xi R; Zhang X
Oncol Lett; 2015 Nov; 10(5):3008-3012. PubMed ID: 26722280
[TBL] [Abstract][Full Text] [Related]
27. Serum anti-TOPO48 autoantibody as a biomarker for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma.
Zhang JB; Cao M; Chen J; Ye SR; Xie K; He X; Ma XL; Zhang J; Yie SM
Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):276-284. PubMed ID: 29170084
[TBL] [Abstract][Full Text] [Related]
28. Predictive Value of Serum miR-10b, miR-29c, and miR-205 as Promising Biomarkers in Esophageal Squamous Cell Carcinoma Screening.
Xu H; Yao Y; Meng F; Qian X; Jiang X; Li X; Gao Z; Gao L
Medicine (Baltimore); 2015 Nov; 94(44):e1558. PubMed ID: 26554762
[TBL] [Abstract][Full Text] [Related]
29. Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma.
Yang Y; Huang X; Zhou L; Deng T; Ning T; Liu R; Zhang L; Bai M; Zhang H; Li H; Ba Y
BMC Cancer; 2019 May; 19(1):526. PubMed ID: 31151431
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of miR-138 predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Zheng S; Zhang X; Wang X; Li J
Cancer Biomark; 2017 Jul; 20(1):49-54. PubMed ID: 28759955
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of preoperative serum tumor markers in esophageal squamous cell carcinoma.
Zhao H; Chen W; Wu J; Wang L; Mao W
J Cancer Res Ther; 2014 Nov; 10 Suppl():C179-85. PubMed ID: 25450279
[TBL] [Abstract][Full Text] [Related]
32. Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
Wang W; He X; Zheng Z; Ma X; Hu X; Wu D; Wang M
Mol Cancer; 2017 Apr; 16(1):75. PubMed ID: 28376832
[TBL] [Abstract][Full Text] [Related]
33. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma.
Komatsu S; Ichikawa D; Takeshita H; Tsujiura M; Morimura R; Nagata H; Kosuga T; Iitaka D; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Otsuji E
Br J Cancer; 2011 Jun; 105(1):104-11. PubMed ID: 21673684
[TBL] [Abstract][Full Text] [Related]
34. Serum miR-21 expression in human esophageal squamous cell carcinomas.
Cai EH; Gao YX; Wei ZZ; Chen WY; Yu P; Li K
Asian Pac J Cancer Prev; 2012; 13(4):1563-7. PubMed ID: 22799367
[TBL] [Abstract][Full Text] [Related]
35. Comparative evaluation of serum C-reactive protein (CRP) levels in the different histological subtypes of esophageal cancer (squamous cell carcinoma and adenocarcinoma of esophagus).
Lukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Siewko M; Szmitkowski M
J Clin Lab Anal; 2012 Feb; 26(2):73-81. PubMed ID: 22467322
[TBL] [Abstract][Full Text] [Related]
36. Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma.
Takeshita N; Hoshino I; Mori M; Akutsu Y; Hanari N; Yoneyama Y; Ikeda N; Isozaki Y; Maruyama T; Akanuma N; Komatsu A; Jitsukawa M; Matsubara H
Br J Cancer; 2013 Feb; 108(3):644-52. PubMed ID: 23361059
[TBL] [Abstract][Full Text] [Related]
37. Serum exosomal miR-182 upregulation predicts unfavorable prognosis of esophageal squamous cell carcinoma.
Qiu ML; Li X; Lin JB; Luo RG; Liu B; Feng Z
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5412-5418. PubMed ID: 32495876
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-155 acts as a diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma.
Zheng YJ; Liang TS; Wang J; Zhao JY; Zhai SN; Yang DK; Wang LD
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):977-982. PubMed ID: 32573268
[TBL] [Abstract][Full Text] [Related]
39. Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma.
Ibuki Y; Nishiyama Y; Tsutani Y; Emi M; Hamai Y; Okada M; Tahara H
PLoS One; 2020; 15(4):e0231116. PubMed ID: 32251457
[TBL] [Abstract][Full Text] [Related]
40. Plasma microRNA-19a as a potential biomarker for esophageal squamous cell carcinoma diagnosis and prognosis.
Bai Y; Lin H; Fang Z; Luo Q; Fang Y; Su Y; Hu Q; Duan H; Chen F; Zhang ZY
Biomark Med; 2017 May; 11(5):431-441. PubMed ID: 28621611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
